記住我
aGuangzhou Medical University, Guangzhou, China
bDepartment of Endodontics, Affiliated Stomatology Hospital of Guangzhou Medical University, Guangdong Engineering Research Center of Oral Restoration and Reconstruction, Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou, China
cGuangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Diseases, Guangzhou, China
Log in to MyKarger to check if you already have access to this content.
Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price. Access via DeepDyve Unlimited fulltext viewing Of this article Organize, annotate And mark up articles Printing And downloading restrictions apply Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more Select* The final prices may differ from the prices shown due to specifics of VAT rules.
Article / Publication DetailsFirst-Page Preview
Received: January 21, 2022
Accepted: June 02, 2022
Published online: July 05, 2022
Number of Print Pages: 10
Number of Figures: 0
Number of Tables: 0
ISSN: 0025-7931 (Print)
eISSN: 1423-0356 (Online)
For additional information: https://www.karger.com/RES
AbstractStudies have shown that oral microbiota dysbiosis affects patients’ lung function, promoting the development and acute exacerbation of chronic obstructive pulmonary disease (COPD). In this paper, we review the mechanisms potentially linking COPD with periodontitis. Oral microbiota enters the respiratory system through clinical microaspiration to aggravate lung microbiota dysbiosis and induce lung injury by entering the respiratory tract directly. Appropriate interventions for dysbiosis such as periodontal therapy or oral microbial transplantation may prevent the progression of COPD.
© 2022 S. Karger AG, Basel
References Paster BJ, Olsen I, Aas JA, Dewhirst FE. The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontol 2000. 2006;42(1):80–7. Ogunrinola GA, Oyewale JO, Oshamika OO, Olasehinde GI. The human microbiome and its impacts on health. Int J Microbiol. 2020;2020:1–7. Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017 May 13;389(10082):1931–40. Brandsma CA, Van den Berge M, Hackett TL, Brusselle G, Timens W. Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine. J Pathol. 2020 Apr;250(5):624–35. Spyratos D, Chloros D, Michalopoulou D, Tsiouprou I, Christoglou K, Sichletidis L. Underdiagnosis, false diagnosis and treatment of COPD in a selected population in Northern Greece. Eur J Gen Pract. 2021 Jan;27(1):97–102. Hobbins S, Chapple IL, Sapey E, Stockley RA. Is periodontitis a comorbidity of COPD or can associations be explained by shared risk factors/behaviors? Int J Chron Obstruct Pulmon Dis. 2017;12:1339–49. Krishnan K, Chen T, Paster BJ. A practical guide to the oral microbiome and its relation to health and disease. Oral Dis. 2017 Apr;23(3):276–86. Verma D, Garg PK, Dubey AK. Insights into the human oral microbiome. Arch Microbiol. 2018;200(4):525–40. Sampaio-Maia B, Caldas IM, Pereira ML, Pérez-Mongiovi D, Araujo R. The oral microbiome in health and its implication in oral and systemic diseases. Adv Appl Microbiol. 2016;97:171–210. Vogelmeier CF, Román-Rodríguez M, Singh D, Han MK, Rodríguez-Roisin R, Ferguson GT. Goals of COPD treatment: focus on symptoms and exacerbations. Respir Med. 2020 May;166:105938. Kucukcoskun M, Baser U, Oztekin G, Kiyan E, Yalcin F. Initial periodontal treatment for prevention of chronic obstructive pulmonary disease exacerbations. J Periodontol. 2013 Jul;84(7):863–70. Mohan A, Premanand R, Reddy LN, Rao MH, Sharma SK, Kamity R, et al. Clinical presentation and predictors of outcome in patients with severe acute exacerbation of chronic obstructive pulmonary disease requiring admission to intensive care unit. BMC Pulm Med. 2006 Dec 19;6(1):27. Hoogendoorn M, Hoogenveen RT, Rutten-van Mölken MP, Vestbo J, Feenstra TL. Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach. Eur Respir J. 2011 Mar;37(3):508–15. Ritchie AI, Wedzicha JA. Definition, causes, pathogenesis, and consequences of chronic obstructive pulmonary disease exacerbations. Clin chest Med. 2020 Sep;41(3):421–38. Park H, Shin JW, Park SG, Kim W. Microbial communities in the upper respiratory tract of patients with asthma and chronic obstructive pulmonary disease. PLoS One. 2014;9(10):e109710. Scannapieco FA, Ho AW. Potential associations between chronic respiratory disease and periodontal disease: analysis of National Health and Nutrition Examination Survey III. J Periodontol. 2001 Jan;72(1):50–6. Shi Q, Zhang B, Xing H, Yang S, Xu J, Liu H. Patients with chronic obstructive pulmonary disease suffer from worse periodontal health-evidence from a meta-analysis. Front Physiol. 2018;9:33. Takeuchi K, Matsumoto K, Furuta M, Fukuyama S, Takeshita T, Ogata H, et al. Periodontitis is associated with chronic obstructive pulmonary disease. J Dent Res. 2019 May;98(5):534–40. Parashar P, Parashar A, Saraswat N, Pani P, Pani N, Joshi S. Relationship between respiratory and periodontal health in adults: a case-control study. J Int Soc Prev Community Dent. 2018 Nov–Dec;8(6):560. Si Y, Fan H, Song Y, Zhou X, Zhang J, Wang Z. Association between periodontitis and chronic obstructive pulmonary disease in a Chinese population. J Periodontol. 2012 Oct;83(10):1288–96. Hayes C, Sparrow D, Cohen M, Vokonas PS, Garcia RI. The association between alveolar bone loss and pulmonary function: the VA Dental Longitudinal Study. Ann Periodontol. 1998 Jul;3(1):257–61. Mobbs KJ, van Saene HK, Sunderland D, Davies PD. Oropharyngeal gram-negative bacillary carriage in chronic obstructive pulmonary disease: relation to severity of disease. Respir Med. 1999 Aug;93(8):540–5. Holtfreter B, Richter S, Kocher T, Dörr M, Völzke H, Ittermann T, et al. Periodontitis is related to lung volumes and airflow limitation: a cross-sectional study. Eur Respir J. 2013 Dec;42(6):1524–35. Yang L, Dunlap DG, Qin S, Fitch A, Li K, Koch CD, et al. Alterations in oral microbiota in HIV are related to decreased pulmonary function. Am J Respir Crit Care Med. 2020 Feb 15;201(4):445–57. Beck JM, Schloss PD, Venkataraman A, Twigg H 3rd, Jablonski KA, Bushman FD, et al. Multicenter comparison of lung and oral microbiomes of HIV-infected and HIV-uninfected individuals. Am J Respir Crit Care Med. 2015 Dec 1;192(11):1335–44. Tan L, Tang X, Pan C, Wang H, Pan Y. Relationship among clinical periodontal, microbiologic parameters and lung function in participants with chronic obstructive pulmonary disease. J Periodontol. 2019 Feb;90(2):134–40. Kuwal A, Joshi V, Dutt N, Singh S, Agarwal KC, Purohit G. A prospective study of bacteriological etiology in hospitalized acute exacerbation of COPD patients: relationship with lung function and respiratory failure. Turk Thorac J. 2018 Jan;19(1):19–27. Mayhew D, Devos N, Lambert C, Brown JR, Clarke SC, Kim VL, et al. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations. Thorax. 2018 May;73(5):422–30. Paudel KR, Dharwal V, Patel VK, Galvao I, Wadhwa R, Malyla V, et al. Role of lung microbiome in innate immune response associated with chronic lung diseases. Front Med. 2020;7:554. Liu Z, Zhang W, Zhang J, Zhou X, Zhang L, Song Y, et al. Oral hygiene, periodontal health and chronic obstructive pulmonary disease exacerbations. J Clin Periodontol. 2012 Jan;39(1):45–52. Tan L, Wang H, Li C, Pan Y. 16S rDNA-based metagenomic analysis of dental plaque and lung bacteria in patients with severe acute exacerbations of chronic obstructive pulmonary disease. J Periodontal Res. 2014 Dec;49(6):760–9. Mok SF, Karuthan C, Cheah YK, Ngeow WC, Rosnah Z, Yap SF, et al. The oral microbiome community variations associated with normal, potentially malignant disorders and malignant lesions of the oral cavity. Malays J Pathol. 2017 Apr;39(1):1–15. Brook I, Frazier EH. Immune response to Fusobacterium nucleatum and Prevotella intermedia in the sputum of patients with acute exacerbation of chronic bronchitis. Chest. 2003 Sep;124(3):832–3. Shen TC, Chang PY, Lin CL, Chen CH, Tu CY, Hsia TC, et al. Risk of periodontal diseases in patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study. Medicine. 2015 Nov;94(46):e2047. Marsh PD, Moter A, Devine DA. Dental plaque biofilms: communities, conflict and control. Periodontol 2000. 2011 Feb;55(1):16–35. Chapple ILC, Van der Weijden F, Doerfer C, Herrera D, Shapira L, Polak D, et al. Primary prevention of periodontitis: managing gingivitis. J Clin Periodontol. 2015 Apr;42(Suppl 16):S71–6. Worthington HV, MacDonald L, Poklepovic Pericic T, Sambunjak D, Johnson TM, Imai P, et al. Home use of interdental cleaning devices, in addition to toothbrushing, for preventing and controlling periodontal diseases and dental caries. Cochrane Database Syst Rev. 2019 Apr 10;4(4):Cd012018. Kim SJ, Lee JY, Kim SH, Cho HJ. Effect of interdental cleaning devices on proximal caries. Community Dent Oral Epidemiol. 2021 Aug. Epub ahead of print. Baldomero AK, Siddiqui M, Lo CY, Petersen A, Pragman AA, Connett JE, et al. The relationship between oral health and COPD exacerbations. Int J Chron Obstruct Pulmon Dis. 2019;14:881–92. Kobayashi K, Ryu M, Izumi S, Ueda T, Sakurai K. Effect of oral cleaning using mouthwash and a mouth moisturizing gel on bacterial number and moisture level of the tongue surface of older adults requiring nursing care. Geriatr Gerontol Int. 2017 Jan;17(1):116–21. Al-Kamel A, Baraniya D, Al-Hajj WA, Halboub E, Abdulrab S, Chen T, et al. Subgingival microbiome of experimental gingivitis: shifts associated with the use of chlorhexidine and N-acetyl cysteine mouthwashes. J Oral Microbiol. 2019;11(1):1608141. Pragman AA, Fieberg AM, Reilly CS, Wendt C. Chlorhexidine oral rinses for symptomatic COPD: a randomised, blind, placebo-controlled preliminary study. BMJ Open. 2021 Dec 13;11(12):e050271. Bassis CM, Erb-Downward JR, Dickson RP, Freeman CM, Schmidt TM, Young VB, et al. Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. mBio. 2015 Mar 3;6(2):e00037. Melo-Dias S, Valente C, Andrade L, Marques A, Sousa A. Saliva as a non-invasive specimen for COPD assessment. Respir Res. 2022 Jan 29;23(1):16. Sze MA, Hogg JC, Sin DD. Bacterial microbiome of lungs in COPD. Int J Chron Obstruct Pulmon Dis. 2014;9:229–38. Dy R, Sethi S. The lung microbiome and exacerbations of COPD. Curr Opin Pulm Med. 2016 May;22(3):196–202. Wang J, Li F, Tian Z. Role of microbiota on lung homeostasis and diseases. Sci China Life Sci. 2017 Dec;60(12):1407–15. Einarsson GG, Comer DM, McIlreavey L, Parkhill J, Ennis M, Tunney MM, et al. Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers. Thorax. 2016 Sep;71(9):795–803. Haldar K, George L, Wang Z, Mistry V, Ramsheh MY, Free RC, et al. The sputum microbiome is distinct between COPD and health, independent of smoking history. Respir Res. 2020 Jul 14;21(1):183. Salter SJ, Cox MJ, Turek EM, Calus ST, Cookson WO, Moffatt MF, et al. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol. 2014 Nov 12;12(1):87. Villette R, Autaa G, Hind S, Holm JB, Moreno-Sabater A, Larsen M. Refinement of 16S rRNA gene analysis for low biomass biospecimens. Sci Rep. 2021 May 24;11(1):10741. Tangedal S, Aanerud M, Grønseth R, Drengenes C, Wiker HG, Bakke PS, et al. Comparing microbiota profiles in induced and spontaneous sputum samples in COPD patients. Respir Res. 2017 Aug 29;18(1):164. Grønseth R, Drengenes C, Wiker HG, Tangedal S, Xue Y, Husebø GR, et al. Protected sampling is preferable in bronchoscopic studies of the airway microbiome. ERJ Open Res. 2017 Jul;3(3):00019. Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med Overseas Ed. 2008;359(22):2355–65. Mammen MJ, Sethi S. COPD and the microbiome. Respirology. 2016;21(4):590–9. Mammen MJ, Sethi S. Microbiome in chronic lung diseases. 2017. Pulvirenti G, Parisi GF, Giallongo A, Papale M, Manti S, Savasta S, et al. Lower airway microbiota. Front Pediatr. 2019;7:393. Magrys A. Microbiota: a missing link in the pathogenesis of chronic lung inflammatory diseases. Pol J Microbiol. 2021 Mar;70(1):25–32. Gaeckle NT, Pragman AA, Pendleton KM, Baldomero AK, Criner GJ. The oral-lung axis: the impact of oral health on lung health. Respir Care. 2020 Aug;65(8):1211–20. Venkataraman A, Bassis CM, Beck JM, Young VB, Curtis JL, Huffnagle GB, et al. Application of a neutral community model to assess structuring of the human lung microbiome. mBio. 2015 Jan 20;6(1):e02284–14. Huffnagle GB, Dickson RP, Lukacs NW. The respiratory tract microbiome and lung inflammation: a two-way street. Mucosal Immunol. 2017 Mar;10(2):299–306. Rivera-Chávez F, Winter SE, Lopez CA, Xavier MN, Winter MG, Nuccio SP, et al. Salmonella uses energy taxis to benefit from intestinal inflammation. PLoS Pathog. 2013;9(4):e1003267. Dickson RP, Erb-Downward JR, Freeman CM, McCloskey L, Beck JM, Huffnagle GB, et al. Spatial variation in the healthy human lung microbiome and the adapted island model of lung biogeography. Ann Am Thorac Soc. 2015 Jun;12(6):821–30. Pragman AA, Kim HB, Reilly CS, Wendt C, Isaacson RE. The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLoS One. 2012;7(10):e47305. Pragman AA, Lyu T, Baller JA, Gould TJ, Kelly RF, Reilly CS, et al. The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease. Microbiome. 2018 Jan 9;6(1):7. Scannapieco FA, Mylotte JM. Relationships between periodontal disease and bacterial pneumonia. J Periodontol. 1996 Oct;67(Suppl 10):1114–22. Almeida-da-Silva CLC, Alpagot T, Zhu Y, Lee SS, Roberts BP, Hung SC, et al. Chlamydia pneumoniae is present in the dental plaque of periodontitis patients and stimulates an inflammatory response in gingival epithelial cells. Microb Cell. 2019 Mar 11;6(4):197–208. Bansal M, Khatri M, Taneja V. Potential role of periodontal infection in respiratory diseases: a review. J Med Life. 2013 Sep 15;6(3):244–8. Gleeson K, Eggli DF, Maxwell SL. Quantitative aspiration during sleep in normal subjects. Chest. 1997 May;111(5):1266–72. Azarpazhooh A, Leake JL. Systematic review of the association between respiratory diseases and oral health. J Periodontol. 2006 Sep;77(9):1465–82. Prasanna SJ. Causal relationship between periodontitis and chronic obstructive pulmonary disease. J Indian Soc Periodontol. 2011 Oct;15(4):359. Olsen I, Lambris JD, Hajishengallis G. Porphyromonas gingivalis disturbs host-commensal homeostasis by changing complement function. J Oral Microbiol. 2017;9(1):1340085. Benedyk M, Mydel PM, Delaleu N, Płaza K, Gawron K, Milewska A, et al. Gingipains: critical factors in the development of aspiration pneumonia caused by Porphyromonas gingivalis. J Innate Immun. 2016;8(2):185–98. Watanabe N, Yokoe S, Ogata Y, Sato S, Imai K. Exposure to Porphyromonas gingivalis induces production of proinflammatory cytokine via TLR2 from human respiratory epithelial cells. J Clin Med. 2020 Oct 26;9(11):3433. Chen Y, Zhou R, Yi Z, Li Y, Fu Y, Zhang Y, et al. Porphyromonas gingivalis induced inflammatory responses and promoted apoptosis in lung epithelial cells infected with H1N1 via the Bcl-2/Bax/Caspase-3 signaling pathway. Mol Med Rep. 2018 Jul;18(1):97–104. Scannapieco FA, Wang B, Shiau HJ. Oral bacteria and respiratory infection: effects on respiratory pathogen adhesion and epithelial cell proinflammatory cytokine production. Ann Periodontol. 2001 Dec;6(1):78–86. Pan Y, Teng D, Burke AC, Haase EM, Scannapieco FA. Oral bacteria modulate invasion and induction of apoptosis in HEp-2 cells by Pseudomonas aeruginosa. Microb Pathog. 2009 Feb;46(2):73–9. Vadiraj S, Nayak R, Choudhary GK, Kudyar N, Spoorthi BR. Periodontal pathogens and respiratory diseases- evaluating their potential association: a clinical and microbiological study. J Contemp Dent Pract. 2013 Jul 1;14(4):610–5. Li Q, Pan C, Teng D, Lin L, Kou Y, Haase EM, et al. Porphyromonas gingivalis modulates Pseudomonas aeruginosa-induced apoptosis of respiratory epithelial cells through the STAT3 signaling pathway. Microbes Infect. 2014 Jan;16(1):17–27. Thomas C, Minty M, Vinel A, Canceill T, Loubières P, Burcelin R, et al. Oral microbiota: a major player in the diagnosis of systemic diseases. Diagnostics. 2021 Jul 30;11(8):1376. Hayata M, Watanabe N, Tamura M, Kamio N, Tanaka H, Nodomi K, et al. The periodontopathic bacterium Fusobacterium nucleatum induced proinflammatory cytokine production by human respiratory epithelial cell lines and in the lower respiratory organs in mice. Cell Physiol Biochem. 2019;53(1):49–61. Koike R, Cueno ME, Nodomi K, Tamura M, Kamio N, Tanaka H, et al. Heat-killed Fusobacterium nucleatum triggers varying heme-related inflammatory and stress responses depending on primary human respiratory epithelial cell type. Molecules. 2020 Aug;2425(17):3839. Takahashi Y, Watanabe N, Kamio N, Yokoe S, Suzuki R, Sato S, et al. Expression of the SARS-CoV-2 receptor ACE2 and proinflammatory cytokines induced by the periodontopathic bacterium Fusobacterium nucleatum in human respiratory epithelial cells. Int J Mol Sci. 2021 Jan 29;22(3):1352. Li Q, Tan L, Wang H, Kou Y, Shi X, Zhang S, et al. Fusobacterium nucleatum interaction with Pseudomonas aeruginosa induces biofilm-associated antibiotic tolerance via Fusobacterium adhesin A. ACS Infect Dis. 2020 Jul 10;6(7):1686–96. Li Q, Wang H, Tan L, Zhang S, Lin L, Tang X, et al. Oral pathogen Fusobacterium nucleatum coaggregates with Pseudomonas aeruginosa to modulate the inflammatory cytotoxicity of pulmonary epithelial cells. Front Cell Infect Microbiol. 2021;11:643913. Zhou X, Han J, Liu Z, Song Y, Wang Z, Sun Z. Effects of periodontal treatment on lung function and exacerbation frequency in patients with chronic obstructive pulmonary disease and chronic periodontitis: a 2-year pilot randomized controlled trial. J Clin Periodontol. 2014 Jun;41(6):564–72. Sanz M, Herrera D, Kebschull M, Chapple I, Jepsen S, Berglundh T, et al. Treatment of stage I–III periodontitis: the EFP S3 level clinical practice guideline. J Clin Periodontol. 2020 Jul;47 Suppl 22(Suppl 22):4–60. Apessos I, Voulgaris A, Agrafiotis M, Andreadis D, Steiropoulos P. Effect of periodontal therapy on COPD outcomes: a systematic review. BMC Pulm Med. 2021 Mar 18;21(1):92. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature. 2007 Oct 18;449(7164):804–10. Proctor LM. The national institutes of health human microbiome project. Semin Fetal Neonatal Med. 2016 Dec;21(6):368–72. Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol. 2013 Apr;108(4):500–8. Walsh A, Mabee J, Trivedi K. Inflammatory bowel disease. Prim Care Clin Off Pract. 2011 Sep;38(3):415–32. Pozhitkov AE, Leroux BG, Randolph TW, Beikler T, Flemmig TF, Noble PA. Towards microbiome transplant as a therapy for periodontitis: an exploratory study of periodontitis microbial signature contrasted by oral health, caries and edentulism. BMC Oral Health. 2015 Oct 14;15(1):125. AbdelMassih A, Gadalla M, Hussein E, Elahmady M, Zahra N, Eid MA, et al. The forgotten oral microbial transplantation for improving the outcomes of COVID-19. New Microbes New Infect. 2021 Sep;43:100923. Lin M, Li X, Wang J, Cheng C, Zhang T, Han X, et al. Saliva microbiome changes in patients with periodontitis with and without chronic obstructive pulmonary disease. Front Cell Infect Microbiol. 2020;10:124. Article / Publication DetailsFirst-Page Preview
Received: January 21, 2022
Accepted: June 02, 2022
Published online: July 05, 2022
Number of Print Pages: 10
Number of Figures: 0
Number of Tables: 0
ISSN: 0025-7931 (Print)
eISSN: 1423-0356 (Online)
For additional information: https://www.karger.com/RES
Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
留言 (0)